Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

6 Stock Charts To Watch: CBLI, COE, GILD, MRNA, NNVC, VIR

Published 02/27/2020, 03:16 AM
Updated 07/09/2023, 06:31 AM

Cleveland BioLabs (NASDAQ:CBLI) popped out of a falling wedge on Tuesday, followed through on Wednesday, popping 1.11, or 48.68%, to 3.39, after reaching a late afternoon high of 4.90, on 4 million shares traded. That’s the best volume in about 3-4 weeks. I think it’s going to run up and test the highs at 4 1/2, and it may blow through that. It depends on the momentum.

China Online Education Group (NYSE:COE), which we highlighted on Tuesday, was up 4.84, or 16%, to 34.84, after reaching up past my target high of 35, to a high of 36.17, on 597,353 shares traded, and in after hours it’s up 53 cents, or another 1.50%, to 35.36. This stock moved from the Dec lows at about 5 1/2 to Wednesday’s high at 36. It’s long-in-the-tooth and spiking up on volume. I would exit this stock on any additional up-move in here.

Gilead Sciences (NASDAQ:GILD), another biotech stock that is working with the government, broke out on Tuesday, pulled back, and on Wednesday, it exploded 4.60, or 6.56%, to 74.70, reaching as high as 75.46 a half hour before closing, on a strong 31 million shares traded. I think it’s headed to 78-79 next.

Moderna (NASDAQ:MRNA), after popping 5.17 on Tuesday, popped another 5.40 on Wednesday, or 22.73%, going from 27.09 to 29.98, before pulling back and closing up 29.16, on 75 million shares traded. That’s over 10.50 and nearly 150 million shares traded in two days. Is it at resistance? Yes. It could pull back and consolidate, but if it does get through here, it could see mid-30’s on Thursday.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

NanoViricides (NYSE:NNVC) popped out of a wedge, pulled back, and then came on again on Wednesday, gaining 1.27, or 16%, to 9.17, with a high of 9.89, on 4.8 million shares traded. It needs to extend past 10.90 to really get going. If it does, it will probably get up to 18 going forward.

Vir Biotechnology (NASDAQ:VIR) broke out on Tuesday, taking it up to 21, and on Wednesday it flew by my targets of 24 and 27, exploding 13.24, or 61%, to session and multi-week highs at 36.50, before closing up 34.97, on 3.9 million shares traded, and adding another 2.53, or 7.22%, to 37.50 in after hours. I don’t know how much more it got to go, but I wouldn’t be surprised to see 40 Thursday morning.

Stocks on the long side

Allied Healthcare Products, Inc. (AHPI), Alpha Pro Tech, Ltd. (APT), Atomera Incorporated (ATOM), BioXcel Therapeutics, Inc. (BTAI), Cleveland BioLabs, Inc. (CBLI), Co-Diagnostics, Inc. (CODX), China Online Education Group (COE), the VelocityShares 3x Inverse Crude S&P GSCI Crude Oil Index (DWT), Gilead Sciences, Inc. (NASDAQ:GILD), Lakeland Industries, Inc. (LAKE), Moderna, Inc. (MRNA), NanoViricides, Inc. (NNVC), Novavax, Inc. (NVAX), Purple Innovation, Inc. (PRPL), Tarena International, Inc. (TEDU), and Vir Biotechnology, Inc. (VIR).

On the short side

Stocks included Aaron's, Inc. (AAN), Arch Coal, Inc. (ARCH), Aramark (ARMK), Core Laboratories (CLB), CVR Energy, Inc. (CVI), Delek US Holdings, Inc. (DK), MGP Ingredients, Inc. (MGPI), Roku, Inc. (ROKU), Six Flags Entertainment Corporation (SIX), TripAdvisor, Inc. (TRIP), and Tractor Supply Company (NASDAQ:TSCO).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Watch video here...

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.